These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 39357273)

  • 1. Siglecs as modulators of macrophage phenotype and function.
    Kukan EN; Fabiano GL; Cobb BA
    Semin Immunol; 2024 May; 73():101887. PubMed ID: 39357273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in understanding and exploiting Siglec-glycan interactions.
    Jame-Chenarboo Z; Gray TE; Macauley MS
    Curr Opin Chem Biol; 2024 Jun; 80():102454. PubMed ID: 38631213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leishmania donovani Utilize Sialic Acids for Binding and Phagocytosis in the Macrophages through Selective Utilization of Siglecs and Impair the Innate Immune Arm.
    Roy S; Mandal C
    PLoS Negl Trop Dis; 2016 Aug; 10(8):e0004904. PubMed ID: 27494323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Siglec Ligands.
    Gonzalez-Gil A; Schnaar RL
    Cells; 2021 May; 10(5):. PubMed ID: 34065256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current Status on Therapeutic Molecules Targeting Siglec Receptors.
    Lenza MP; Atxabal U; Oyenarte I; Jiménez-Barbero J; Ereño-Orbea J
    Cells; 2020 Dec; 9(12):. PubMed ID: 33333862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural advances of Siglecs: insight into synthetic glycan ligands for immunomodulation.
    Movsisyan LD; Macauley MS
    Org Biomol Chem; 2020 Aug; 18(30):5784-5797. PubMed ID: 32756649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Probing the binding specificities of human Siglecs by cell-based glycan arrays.
    Büll C; Nason R; Sun L; Van Coillie J; Madriz Sørensen D; Moons SJ; Yang Z; Arbitman S; Fernandes SM; Furukawa S; McBride R; Nycholat CM; Adema GJ; Paulson JC; Schnaar RL; Boltje TJ; Clausen H; Narimatsu Y
    Proc Natl Acad Sci U S A; 2021 Apr; 118(17):. PubMed ID: 33893239
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensing the neuronal glycocalyx by glial sialic acid binding immunoglobulin-like lectins.
    Linnartz-Gerlach B; Mathews M; Neumann H
    Neuroscience; 2014 Sep; 275():113-24. PubMed ID: 24924144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and expression of 3 siglecs-like in Oreochromis niloticus neutrophil, and their interaction with group B streptococcal sialylated capsular polysaccharides.
    Dong J; Wei Y; Ye X; Sun C; Tian Y; Lu M; Du J; Chen Z
    Mol Immunol; 2016 May; 73():158-69. PubMed ID: 26847490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation of Recombinant Siglecs and Identification of Their Ligands.
    Chang LY; Low PY; Sridharan D; Gerlovin K; Angata T
    Methods Mol Biol; 2020; 2132():85-98. PubMed ID: 32306317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Siglec Signaling in the Tumor Microenvironment.
    van Houtum EJH; Büll C; Cornelissen LAM; Adema GJ
    Front Immunol; 2021; 12():790317. PubMed ID: 34966391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B Cell Siglecs-News on Signaling and Its Interplay With Ligand Binding.
    Meyer SJ; Linder AT; Brandl C; Nitschke L
    Front Immunol; 2018; 9():2820. PubMed ID: 30559744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Siglecs as Immune Cell Checkpoints in Disease.
    Duan S; Paulson JC
    Annu Rev Immunol; 2020 Apr; 38():365-395. PubMed ID: 31986070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Siglecs: A journey through the evolution of sialic acid-binding immunoglobulin-type lectins.
    Bornhöfft KF; Goldammer T; Rebl A; Galuska SP
    Dev Comp Immunol; 2018 Sep; 86():219-231. PubMed ID: 29751010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of CD33-related siglecs: regulating host immune functions and escaping pathogen exploitation?
    Cao H; Crocker PR
    Immunology; 2011 Jan; 132(1):18-26. PubMed ID: 21070233
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The membrane-proximal immunoreceptor tyrosine-based inhibitory motif is critical for the inhibitory signaling mediated by Siglecs-7 and -9, CD33-related Siglecs expressed on human monocytes and NK cells.
    Avril T; Floyd H; Lopez F; Vivier E; Crocker PR
    J Immunol; 2004 Dec; 173(11):6841-9. PubMed ID: 15557178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of the Siglec family in bone and bone homeostasis.
    Ye Z; Wang Y; Xiang B; Wang H; Tao H; Zhang C; Zhang S; Sun D; Luo F; Song L
    Biomed Pharmacother; 2023 Sep; 165():115064. PubMed ID: 37413904
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tools to study and target the Siglec-sialic acid axis in cancer.
    Läubli H; Kawanishi K; George Vazhappilly C; Matar R; Merheb M; Sarwar Siddiqui S
    FEBS J; 2021 Nov; 288(21):6206-6225. PubMed ID: 33251699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways.
    Angata T; Varki A
    J Biol Chem; 2000 Jul; 275(29):22127-35. PubMed ID: 10801860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sialic Acid-Siglec Axis in Human Immune Regulation, Involvement in Autoimmunity and Cancer and Potential Therapeutic Treatments.
    Gianchecchi E; Arena A; Fierabracci A
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34071314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.